MedX Health Corp. MDXHF

0.03 0.00 0.00% as of 24 Sep
Market cap
$103.2M
P/E
0.0×
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
8.75 0.00 0.02 0.01 0.26 0.26 0.00 0.00 0.00 0.00
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
(3.70) 0.00 (0.15) (0.03) (1.68) (0.40) (0.49) (0.47) (0.47) (0.47)
P/B ratio
0.00 0.00 0.15 0.03 0.20 1.40 0.23 0.17 0.17 0.17
Price to Tangible BV
0.00 0.00 0.00 0.00 0.22 10.32 0.36 0.27 0.27 0.27
EV/Sales
12.29 5.93 0.26 0.63 (0.95) 0.24 0.00 0.00 0.00 0.00
EV/EBITDA
0.00 0.00 0.00 4.33 0.77 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
(1.56) (1.16) (0.86) (0.69) 0.63 (0.13) 0.00 0.00 0.00 0.00
EV/FCF
(0.79) (0.47) (0.62) (0.60) 0.63 (0.13) 0.00 0.00 0.00 0.00
Quick Ratio
0.01 0.05 1.71 1.36 3.84 1.51 2.76 3.95 2.80 3.93
Current Ratio
0.04 0.10 1.95 1.59 4.05 1.77 2.96 4.17 3.00 4.09
Net Debt/EBITDA
(0.40) (1.29) (0.85) (0.66) 1.84 0.04 0.33 0.87 1.48 2.80
Debt/Assets
241.50% 346.44% 30.81% 32.42% 19.60% 47.44% 27.08% 0.80% 0.00% 0.79%
Debt/Equity
(0.17) (0.36) 5.52 4.15 0.31 2.58 0.56 0.01 0.02 0.01
Asset Turnover
0.59 0.01 0.57 0.38 0.42 0.48 0.22 0.87 1.28 0.45
Operating CF/Net income
0.59 0.69 0.50 0.77 0.78 0.71 0.52 0.89 0.85 1.26
Capex/Depreciation
(0.04) (34.74) (0.40) (0.57) (0.30) (0.16) 0.00 0.00 0.00 0.00
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
68.26% (540.15%) (521.70%) (156.70%) (109.96%) (204.65%) (118.02%) (72.01%) (27.25%) (26.03%)
ROA
(784.34%) (4.11%) (34.72%) (45.36%) (54.25%) (73.96%) (80.10%) (99.12%) (38.84%) (19.85%)
ROIC
0.00% 0.00% (69.39%) (77.00%) (538.20%) (338.36%) 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
66.31% 49.04% (182.67%) (300.40%) (55.94%) (259.55%) (187.95%) (84.37%) (45.47%) (30.52%)
Average Days of Receivables
97.96 219.06 57.66 92.17 75.20 74.56 207.35 245.91 168.69 237.51
Research and Development Expense of Revenue
105.64% 107.47% 9.08% 20.39% 30.01% 24.61% 21.78% 10.93% 7.20% 4.43%
Selling, General and Administrative Expense of Revenue
789.78% 402.63% 86.03% 130.76% 138.19% 165.89% 261.93% 151.56% 92.67% 99.92%
Intangible Assets out of Total Assets
155.90 118.58 0.62 0.69 0.05 0.16 0.18 0.24 0.00 0.21
Share Based Compensation of Revenue
183.20% 28.26% 0.95% 2.34% 5.49% 7.02% 0.00% 0.00% 0.00% 0.00%
Graham Net Nets
(2.42) 0.00 (76.20) (256.07) 4.11 (0.36) 2.24 3.17 3.17 3.17
Graham Number
0.09 0.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
(152.00%) 0.00% (2,850.00%) (9,500.00%) (899.17%) (1,143.78%) (1,143.78%) (1,143.78%) (1,143.78%) (1,143.78%)
Free Cash Flow Yield
(178.45%) 0.00% (2,726.26%) (12,294.31%) (585.61%) (677.37%) 0.00% 0.00% 0.00% 0.00%
Revenue per Share
0.00 0.00 2.70 2.36 0.18 2.22 2.12 5.67 0.87 0.62
Operating CF per Share
(0.01) (0.01) (0.83) (2.17) (0.19) (2.43) (4.06) (5.77) (0.22) (0.34)
Capex per Share
0.00 0.00 (0.11) (0.18) (0.01) (0.06) 0.00 0.00 0.00 0.00
Free Cash Flow per Share
(0.01) (0.01) (0.93) (2.35) (0.19) (2.50) (4.06) (5.77) (0.22) (0.34)
Cash per Share
0.00 0.00 0.86 0.99 0.48 1.92 3.96 5.23 0.34 0.67
Shareholders Equity per Share
(0.02) (0.02) 0.28 0.59 0.39 0.70 3.54 10.40 0.88 1.14
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
(0.02) (0.02) 0.28 0.59 0.39 0.70 3.54 10.40 0.88 1.14
Free Cash Flow
(2.67) (3.02) (24.24) (36.91) (23.44) (20.78) (25.41) (33.26) (11.20) (15.78)
Working Capital
(7.00) (5.46) 18.64 10.87 50.17 10.07 23.01 41.82 26.29 38.82
Capital Expenditures
0.00 (1.19) (2.75) (2.79) (0.90) (0.54) (0.08) (1.55) (5.19) (4.65)
Net Current Asset Value
(7.18) (6.25) (83.76) (80.67) 38.43 (2.92) 11.24 39.66 24.42 36.43
EV/EBIT
0.00 0.00 0.00 46.22 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.00 3.32 0.04 0.08 0.04 0.03 0.00 0.00 0.00 0.00
Net Profit Margin
(1,329.23%) (745.91%) (61.40%) (118.86%) (130.41%) (155.27%) (365.72%) (114.27%) (30.33%) (43.96%)
Price to Operating Income
0.00 0.00 0.00 0.62 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.18 1.19 1.38 1.29 1.82 3.42 1.39 1.42 0.78 0.73
Cash ROIC
50.14% 48.09% (38.13%) (59.76%) (20.16%) (57.47%) (47.49%) (39.33%) (22.42%) (21.47%)
Accounts Receivable Turnover
2.22 0.06 6.87 5.32 5.32 3.27 0.90 1.55 2.24 1.48
Accounts Payable Turnover
0.22 0.04 2.77 2.02 1.83 1.91 3.35 3.13 2.18 1.84
Inventory Turnover
1.84 0.14 10.29 8.42 5.51 5.69 9.98 8.38 7.79 6.58
Average Days of Payables
1,700.43 2,945.56 122.45 208.30 233.07 186.42 119.25 100.23 168.29 196.82
Days of Inventory on Hand
130.17 465.22 38.62 47.62 59.74 81.44 28.67 45.21 53.07 48.15
Average Receivables
0.15 5.65 10.22 6.97 4.18 5.65 14.76 20.99 19.28 19.28
Average Payables
1.75 5.28 9.49 8.82 6.39 5.45 5.09 5.36 6.07 6.07
Average Inventory
0.20 1.53 2.55 2.12 2.12 1.83 1.71 2.00 1.70 1.70
Average Assets
0.57 64.89 124.13 97.10 53.46 38.75 60.45 37.63 33.79 63.15
Average Common Equity
(6.60) 0.49 8.26 28.11 26.37 14.01 41.03 51.80 48.16 48.16

Fold the line items

Columns are period end dates